Condition
Spinocerebellar Ataxia Type 7
Total Trials
5
Recruiting
1
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 3 (1)
Trial Status
Active Not Recruiting2
Completed1
Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04288128Completed
Integrated Functional Evaluation of the Cerebellum
NCT03701399Phase 3Active Not Recruiting
Troriluzole in Adult Participants With Spinocerebellar Ataxia
NCT01793168Recruiting
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
NCT05826171Not ApplicableActive Not Recruiting
Priming Motor Learning Through Exercise in People With Spinocerebellar Ataxia
NCT04301284Phase 2Withdrawn
Study of CAD-1883 for Spinocerebellar Ataxia
Showing all 5 trials